[go: up one dir, main page]

WO2006060202A3 - Derives d'imidazole utilises dans le traitement de troubles psychiatriques - Google Patents

Derives d'imidazole utilises dans le traitement de troubles psychiatriques Download PDF

Info

Publication number
WO2006060202A3
WO2006060202A3 PCT/US2005/042007 US2005042007W WO2006060202A3 WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3 US 2005042007 W US2005042007 W US 2005042007W WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
psychiatric disorders
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/042007
Other languages
English (en)
Other versions
WO2006060202A2 (fr
Inventor
Astrid Ortiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of WO2006060202A2 publication Critical patent/WO2006060202A2/fr
Publication of WO2006060202A3 publication Critical patent/WO2006060202A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des dérivés d'imidazole utiles dans le traitement de troubles psychiatriques.
PCT/US2005/042007 2004-11-30 2005-11-18 Derives d'imidazole utilises dans le traitement de troubles psychiatriques Ceased WO2006060202A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63202804P 2004-11-30 2004-11-30
US60/632,028 2004-11-30

Publications (2)

Publication Number Publication Date
WO2006060202A2 WO2006060202A2 (fr) 2006-06-08
WO2006060202A3 true WO2006060202A3 (fr) 2006-12-14

Family

ID=36565537

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042007 Ceased WO2006060202A2 (fr) 2004-11-30 2005-11-18 Derives d'imidazole utilises dans le traitement de troubles psychiatriques

Country Status (1)

Country Link
WO (1) WO2006060202A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Also Published As

Publication number Publication date
WO2006060202A2 (fr) 2006-06-08

Similar Documents

Publication Publication Date Title
AP2379A (en) Imidazole compounds for the treatment of neurodegenerative disorders.
WO2006071960A3 (fr) Compositions et procedes de traitement de troubles de la proliferation cellulaire
IL189990A0 (en) 5-(phenylisoxazolylethoxy) -triazol-3-yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders
HRP20130797T1 (en) Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
IL180736A0 (en) Hydantoin derivatives for the treatment of inflammatory disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
WO2005079756A3 (fr) Methodes et compositions de traitement de troubles psychiatriques
WO2006017384A3 (fr) Indazoles utiles dans le traitement de maladies cardio-vasculaires
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2006018188A3 (fr) Hydantoines substituees
IL186748A0 (en) 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility
SI1900362T1 (sl) Derivati alfa-aminoamida, uporabni pri zdravljenju odvisnosti
ZA200805159B (en) Imidazole derivatives for the treatment of gastrointestinal disorders
WO2007047447A3 (fr) Analogues de compose diuretique ou de type diuretique
IL189524A0 (en) Imidazole compounds for the treatment of neurological disorders
EP1814535A4 (fr) Composes nitroses et nitrosyles, compositions et procedes destines au traitement de troubles ophtalmiques
WO2008050133A3 (fr) Inhibition d'une agrégation de beta-amyloïde
WO2005112923A3 (fr) Dérivés de 5-anilino-4-hétéroarylpyrazole utiles pour le traitement du diabete
WO2007030438A3 (fr) Derives d'aminopurine permettant de traiter maladies neurodegeneratives
WO2006060202A3 (fr) Derives d'imidazole utilises dans le traitement de troubles psychiatriques
MX2007009108A (es) Derivados de imidazol.
WO2006060201A3 (fr) Derives de pyrazole utilises dans le traitement de troubles psychiatriques
WO2006060203A3 (fr) Derives d'imidazole utilises dans le traitement de la demence et des troubles associes
WO2006060199A3 (fr) Derives d'imidazole utilises dans le traitement des dysfonctionnements sexuels
WO2006060192A3 (fr) Derives de pyrazole

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05849389

Country of ref document: EP

Kind code of ref document: A2